Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Price to FCF (2020 - 2021)

Updated

Kymera Therapeutics' (KYMR) Price to FCF was 40.99 for Q2 2021, up 63.4% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Price to FCF (2020 - 2021) Analysis & Trends

For FY2020, Price to FCF at Kymera Therapeutics was 13.61.

  • Per Business Quant data, the three quarters before Q2 2021 came in at 25.09 (Q1 2021), 13.61 (Q4 2020) and 7.46 (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kymera Therapeutics 8.89 Bn 6.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 40.99
Mar 31, 2021 25.09
Dec 31, 2020 13.61
Sep 30, 2020 7.46
API Access

Kymera Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=KYMR&period=max&api_key=YOUR_API_KEY